Article

Mmarketwatch.com on 2018-01-16 19:37

Merck leaps past rivals with latest lung cancer drug results

Smoking, which causes many lung cancer cases, has made advanced lung cancer a big market for pharmaceutical companies, and the competition has been fierce.

Brad Loncar

Related news

MMerck shares rise after beating rivals' lung cancer results marketwatch.com
MUPDATE: Merck shares jump 7% on news of positive results from lung cancer trial marketwatch.com
MBristol-Myers stock drops nearly 9% after Merck announces positive lung cancer drug results marketwatch.com
MMerck stock rises 2.4% after new Keytruda lung cancer approval marketwatch.com
MBristol-Myers touts lung cancer breakthrough, but critics cry foul marketwatch.com
Bristol
MMerck stock slides as lung-cancer drug misses a study endpoint marketwatch.com
MMerck shares surge anew on lung cancer advance, while Bristol-Myers stock plummets marketwatch.com
Drug boost in lung cancer fight expressandstar.com
Chicago , Spain , Seville , Europe , North America
MBristol-Myers surges 5.6% on advanced lung cancer trial results, Q4 earnings marketwatch.com
Lung cancer: Treatment 'frustrating'NZ Herald
Europe , Wellington , Rotorua , United States , Australia
How Big Can Merck's Keytruda Be In Lung Cancer?Forbes
Bristol
Merck Hedges Bets With Keytruda Lung Study Forbes
Bristol
Merck reports surging sales of vaccines and key cancer drug bradenton.com
New Jersey , China , Wall Street , Kenilworth
Progress In Cancer Drug Lifts Merck Earnings, Sending Stock Higher Forbes
Wall Street
Merck seeks new OK for cancer drug, reorganization on track The Wichita Eagle
Bristol , Whitehouse Station , New Jersey , Kenilworth